State Health Fraud Task Force Grants; Availability of Funds; Request for Applications; Correction, 9656-9657 [05-3710]

Agencies

• Food and Drug Administration
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 70, Number 38 (Monday, February 28, 2005)]
[Notices]
[Pages 9656-9657]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-3710]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


State Health Fraud Task Force Grants; Availability of Funds; 
Request for Applications; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is correcting notice 
document 04-14593 beginning on page 36091 in the issue of Monday, June 
28, 2004, by making the following corrections:
    On page 36091, in the first column, the second sentence under 
SUMMARY is corrected to read: ``Grant funds will be used to assist 
agencies in identifying and prosecuting perpetrators of health fraud 
and AIDS Health Fraud; obtain and disseminate information on the use of 
fraudulent drugs and therapies; disseminate information on approved 
drugs and therapies; and provide health fraud information obtained by 
the State Health Fraud Task Force to State health agencies, community 
based organizations, and FDA staff.''
    On page 36091, in the first column, the DATES section is corrected 
to read:
``DATES: The application receipt date for new applications is April 30, 
2005. The application receipt date for new applications for each 
subsequent year that this program is in effect will be April 30.''
    On page 36091, in the first column, the ADDRESSES section is 
corrected to read:
``ADDRESSES: FDA is accepting new applications for this program 
electronically via Grants.gov. Applicants are strongly encouraged to 
apply electronically by visiting the Web site https://www.grants.gov and 
following instructions under `APPLY.' The applicant must register in 
the Central Contractor Registration (CCR) database in order to be able 
to submit the application. Information about CCR is available at http:/
/www.grants.gov/CCRRegister. The applicant must register with the 
Credential Provider for Grants.gov. Information about this requirement 
is available at https://www.grants.gov/CredentialProvider.
    If applicants cannot submit applications through the electronic 
process, application forms are available from, and completed 
applications should be submitted to, Djuana Gibson, Division of 
Contracts and Grants Management (HFA-500), Food and Drug 
Administration, 5600 Fishers Lane, rm. 2131, Rockville, MD 20857, 301-
827-

[[Page 9657]]

7177, e-mail: dgibson@oc.fda.gov. Application forms PHS 5161-1 are 
available via the Internet at: https://www.hhs.gov/forms (revised 7/00). 
Applications hand-carried or commercially delivered should be addressed 
to 5630 Fishers Lane (HFA-500), rm. 2131, Rockville, MD 20852. An 
application not received in time for orderly processing will be 
returned to the applicant without consideration.''
    On page 36091, in the second column, FOR FURTHER INFORMATION 
CONTACT is corrected to read:
``FOR FURTHER INFORMATION CONTACT:
    Regarding the administrative and financial management aspects of 
this notice: Djuana Gibson (see ADDRESSES).
    Regarding the programmatic aspects of this notice: Stephen Toigo, 
Division of Federal-State Relations (DFSR), Office of Regulatory 
Affairs, Food and Drug Administration (HFC-150), 5600 Fishers Lane, rm. 
12-07, Rockville, MD 20857, 301-827-6906, or access the Internet at: 
https://www.fda.gov/ora/fed_state/default.htm. For general ORA program 
information contact your Public Affairs Specialists at https://
www.fda.gov/ora/fed_state/DFSR_Activities/.''
    On page 36091, in the second column, under section I, the first 
paragraph is corrected to read: ``FDA will support projects covered by 
this notice under title XVII of the Public Health Service Act (42 
U.S.C. 1702). FDA's project program is described in the Catalog of 
Federal Domestic Assistance, No. 93.245, and applicants are limited to 
States that have an existing AIDS Health Fraud Task Force or States 
that are in the process of developing a Health Fraud Task Force.''
    On page 30692, in the first column, under section V.A, a sentence 
is added at the end of the paragraph that reads: ``A Current Listing of 
SPOCs can be found at https://www.whitehouse.gov/omb/grants/spoc.html.''
    On page 36092, in the third column, under section VII, the 
paragraph is corrected to read: ``Applicants are encouraged to apply 
electronically (see ADDRESSES). If not, the original and two copies of 
the completed grant application Form PHS-5161-1 (revised 7/00) for 
State and local governments should be delivered to the Grants 
Management Office. The receipt date is April 30, 2005. No supplemental 
material or addenda will be accepted after the receipt date.''
    On page 36092, in the third column, under section VIII.A, the 
section is corrected to read:

``A. Submission Instructions
    Applications will be accepted during working hours, 8 a.m. to 4:30 
p.m., Monday through Friday, on or before the established receipt date. 
Applications will be considered received on time if sent or mailed on 
or before the receipt date as evidenced by a legible U.S. Postal 
Service dated postmark or a legible date receipt from a commercial 
carrier, unless they arrive too late for orderly processing. Private 
metered postmarks shall not be acceptable as proof of timely mailing. 
Applications not received on time will not be considered for review and 
will be returned to the applicant. Applicants should note that the U.S. 
Postal Service does not uniformly provide dated postmarks. Before 
relying on this method, applicants should check with their local post 
office.
    Do not send applications to the Center for Scientific Research, 
NIH. Any application sent to NIH that is then forwarded to FDA and not 
received in time for orderly processing will be deemed unresponsive and 
returned to the applicant. FDA is able to receive applications via the 
Internet.
    The outside of the mailing package and item 2 of the application 
face page should be labeled `Response to FDA-ORA-04-2.' You must submit 
only one application, an original and two copies, per package.''
    Please note that the only change to section VIII.A is that FDA is 
now accepting applications via the Internet.

    Dated: February 18, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05-3710 Filed 2-25-05; 8:45 am]
BILLING CODE 4160-01-S